🟢 Ionis Pharmaceuticals is trading 5% up today as biotech and major U.S. indexes rally

Ionis Pharmaceuticals is trading 4.96% up at $47.06, primarily as broader risk appetite lifts biotech and major U.S. indexes.

• Rebounding after four consecutive declining sessions.
• Company-specific sentiment remains pressured by Novartis’ September 4 disclosure that pelacarsen’s Phase 3 cardiovascular outcomes study missed its primary endpoint.
• That disclosure drove recent weakness rather than today’s rebound.